sGC\(\alpha_1 \beta_1\) Attenuates Cardiac Dysfunction and Mortality in Murine Inflammatory Shock Models by Cauwels, Anje et al.
 
sGC\(\alpha_1 \beta_1\) Attenuates Cardiac Dysfunction and
Mortality in Murine Inflammatory Shock Models
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Buys, Emmanuel S., Anje Cauwels, Michael J. Raher, Jonathan J.
Passeri, Ion Hobai, Sharon M. Cawley, Kristen M. Rauwerdink, et
al. 2009. sGC\(\alpha_1 \beta_1\) attenuates cardiac dysfunction
and mortality in murine inflammatory shock models. BMC
Pharmacology 9(Suppl. 1): P5.
Published Version doi:10.1186/1471-2210-9-S1-P5
Accessed February 19, 2015 9:55:29 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10318216
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAABioMed  Central
Page 1 of 1
(page number not for citation purposes)
BMC Pharmacology
Open Access Poster presentation
sGCα1β1 attenuates cardiac dysfunction and mortality in murine 
inflammatory shock models
Emmanuel S Buys*1,2, Anje Cauwels3,4, Michael J Raher1,2, 
Jonathan J Passeri5, Ion Hobai1, Sharon M Cawley2, Kristen M Rauwerdink1, 
Helene Thibault5, Patrick Y Sips1, Robrecht Thoonen3,4, Marielle Scherrer-
Crosbie2,5, Fumito Ichinose1, Peter Brouckaert3,4 and Kenneth D Bloch1,2
Address: 1Anesthesia Center for Critical Care Research, Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard 
Medical School, Boston, MA, USA, 2Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 
USA, 3Department of Medical Molecular Biology, Flanders Institute for Biotechnology (VIB), Ghent, Belgium, 4Department of Molecular Biology, 
Ghent University, Ghent, Belgium and 5Cardiac Ultrasound Laboratory, Cardiology Division, Department of Medicine, Massachusetts General 
Hospital, Harvard Medical School, Boston, MA, USA
Email: Emmanuel S Buys* - ebuys@partners.org
* Corresponding author    
Background
Altered cGMP signaling has been implicated in myocar-
dial depression, morbidity, and mortality associated with
sepsis. Previous studies, using inhibitors of soluble guan-
ylate cyclase (sGC), suggested that cGMP generated by
sGC contributed to the cardiac dysfunction and mortality
associated with sepsis. We used mice deficient in sGCα1
(sGCα1
-/-mice) to unequivocally determine the role of
sGCα1β1 in the development of cardiac dysfunction and
death associated with two models of inflammatory shock:
endotoxin-induced and TNF-induced shock.
Results
At baseline, echocardiographic assessment and invasive
hemodynamic measurements of left ventricular (LV)
dimensions and function did not differ between WT and
sGCα1
-/-mice on the C57BL/6 background (sGCα1
-/-B6
mice). Fourteen hours after a challenge with endotoxin,
cardiac dysfunction was more pronounced in sGCα1
-/-B6
mice than in WT mice, as assessed using echocardio-
graphic and hemodynamic indices of LV function. Simi-
larly, Ca2+ handling and cell shortening were impaired to
a greater extent in cardiac myocytes isolated from sGCα1
-/
-B6 mice than in those from WT mice after a challenge with
endotoxin. Importantly, morbidity and mortality associ-
ated with inflammatory shock induced either by endo-
toxin or TNF were increased in sGCα1
-/-B6  mice as
compared to WT mice.
Conclusion
Together, these findings suggest that cGMP generated by
sGCα1β1 protects against cardiac dysfunction and mortal-
ity in murine models of inflammatory shock.
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